Pérez, Y.; Bonet, R.; Corredor, M.; Domingo, C.; Moure, A.; Messeguer, À.; Bujons, J.; Alfonso, I.
Semaphorin 3A—Glycosaminoglycans Interaction as Therapeutic Target for Axonal Regeneration. Pharmaceuticals 2021, 14, 906.
https://doi.org/10.3390/ph14090906
AMA Style
Pérez Y, Bonet R, Corredor M, Domingo C, Moure A, Messeguer À, Bujons J, Alfonso I.
Semaphorin 3A—Glycosaminoglycans Interaction as Therapeutic Target for Axonal Regeneration. Pharmaceuticals. 2021; 14(9):906.
https://doi.org/10.3390/ph14090906
Chicago/Turabian Style
Pérez, Yolanda, Roman Bonet, Miriam Corredor, Cecilia Domingo, Alejandra Moure, Àngel Messeguer, Jordi Bujons, and Ignacio Alfonso.
2021. "Semaphorin 3A—Glycosaminoglycans Interaction as Therapeutic Target for Axonal Regeneration" Pharmaceuticals 14, no. 9: 906.
https://doi.org/10.3390/ph14090906
APA Style
Pérez, Y., Bonet, R., Corredor, M., Domingo, C., Moure, A., Messeguer, À., Bujons, J., & Alfonso, I.
(2021). Semaphorin 3A—Glycosaminoglycans Interaction as Therapeutic Target for Axonal Regeneration. Pharmaceuticals, 14(9), 906.
https://doi.org/10.3390/ph14090906